Enanta Pharmaceuticals, Inc. (ENTA) vs Kyverna Therapeutics, Inc. (KYTX)
A side-by-side comparison of Enanta Pharmaceuticals, Inc. and Kyverna Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENTA
Enanta Pharmaceuticals, Inc.
$12.22HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
KYTX
Kyverna Therapeutics, Inc.
$6.31HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — ENTA vs KYTX
growth of $100 · dividends reinvested · last 3yENTA +1.9% (+0.6%/yr)KYTX -78.9% (-40.5%/yr)ENTA compounded faster over this window
ENTA KYTX
ENTA vs KYTX: by the numbers
- •KYTX is the larger company ($384M vs $355M market cap).
- •Both run net losses; KYTX's is the smaller (0.00% vs -96.89% net margin).
Metrics side by side
Valuation
| Metric | ENTA | KYTX |
|---|---|---|
| P/S ratio | 5.45 | N/A |
| P/B ratio | 3.52 | 2.32 |
Profitability
| Metric | ENTA | KYTX |
|---|---|---|
| Gross margin | 98.15% | 0.00% |
| Operating margin | -130.65% | 0.00% |
| Net margin | -96.89% | 0.00% |
| ROE | -62.56% | -92.20% |
| ROIC | -24.20% | -80.67% |
Growth (annualized)
| Metric | ENTA | KYTX |
|---|---|---|
| Revenue CAGR (5Y) | -7.65% | N/A |
| Total return CAGR (5Y) | -26.94% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.